v3 Template
V

VectorBuilder Inc.

Biotechnology ~120 employees
Founded
--
Employees (Est.)
~120
8 leaders known
Total Funding
$76.0M
Funding Rounds
1
Last Funding
2023-07-26

About VectorBuilder Inc.

VectorBuilder is a global leader in gene delivery technologies, providing a full spectrum of gene delivery solutions for research and clinical needs from bench to bedside. They are a trusted partner for thousands of labs and biotech/pharma companies worldwide.

Products & Services

Vector Design & Cloning:Services for online vector design, vector cloning, and plasmid DNA preparation.
Recombinant Viruses:Packaging services for various viruses including Lentivirus, Adeno-Associated Virus (AAV), Adenovirus, and others.
CRO Services:Includes Therapeutic IVT RNA development, library screening, stable cell line engineering, antibody discovery, and more.
CDMO Services:GMP manufacturing services for plasmid, viral vector, and IVT RNA/LNP production, including the cliniVec™ platform.
Premade Products:Includes popular vectors, premade viruses, libraries, stable cell lines, IVT RNA, and research antibodies.
Featured Offerings:Innovative solutions like miniVec™ Plasmid, AAV gene delivery, CRISPR genome editing, and inducible gene expression systems.
Tools and Resources:Software and online tools for sequence design, analysis, bio calculators, and educational resources like Vector Academy.

Specialties

Gene Delivery Technologies Vector Design and Cloning Viral Vector Manufacturing Therapeutic IVT RNA Development CRISPR Genome Editing Stable Cell Line Engineering Antibody Discovery GMP Manufacturing

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series C
T: -
FT: Series C
A: 76000000
MR: -
FA: just over $76 million
FAN: 76000000
D: 2023-07-26
FD: 2023-07-26
1 investors
Series C Latest
2023-07-26
$76.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

B

Bruce Lahn

Chief Scientist

K

Kristofer Mussar

Chief Operating Officer

J

Jason Ye

Chief Technology Officer

R

Ray Hao

VP of Antibody Discovery

G

Grace Yu

VP of Global Business

T

Tim Reid

Global Sales Director

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

VectorBuilder Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~120 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro